Reme-D

$1.4M pre-Series A

Announced: Jul 24, 2026
Sector: e-health
Investors: 3

Summary

Reme-D raised US$1.45 million in pre-Series A funding to expand its manufacturing capacity, regional footprint, and diagnostic product portfolio. The company develops and manufactures molecular diagnostic tests and plans to broaden its offerings into new disease areas.

Investors

Anara Impact Capital, Global Innovation Fund (GIF), Africa Health Ventures